Serum and urine metabolomic fingerprinting in diagnostics of inflammatory bowel diseases
about
Urinary metabolites as noninvasive biomarkers of gastrointestinal diseases: A clinical reviewNutritional Modulation of Gene Expression: Might This be of Benefit to Individuals with Crohn's Disease?Recommendations and Standardization of Biomarker Quantification Using NMR-Based Metabolomics with Particular Focus on Urinary AnalysisMicrobiome, Metabolome and Inflammatory Bowel DiseaseContribution of metabolic reprogramming to macrophage plasticity and functionStandardizing the experimental conditions for using urine in NMR-based metabolomic studies with a particular focus on diagnostic studies: a reviewMethylsulfonylmethane: Applications and Safety of a Novel Dietary SupplementDevelopmental origins of NAFLD: a womb with a clue.Dietary and metabolomic determinants of relapse in ulcerative colitis patients: A pilot prospective cohort study.Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn's disease and healthy individuals.The promise of metabolic phenotyping in gastroenterology and hepatology.Urine metabolome profiling of immune-mediated inflammatory diseases.Choline Deficiency Causes Colonic Type II Natural Killer T (NKT) Cell Loss and Alleviates Murine Colitis under Type I NKT Cell Deficiency.Limited prolonged effects of rifaximin treatment on irritable bowel syndrome-related differences in the fecal microbiome and metabolome.Systems biology approaches for inflammatory bowel disease: emphasis on gut microbial metabolism.Stability in metabolic phenotypes and inferred metagenome profiles before the onset of colitis-induced inflammation.The Gut Microbiome of Pediatric Crohn's Disease Patients Differs from Healthy Controls in Genes That Can Influence the Balance Between a Healthy and Dysregulated Immune Response.NMR based serum metabolomics reveals a distinctive signature in patients with Lupus Nephritis.Trimethylamine-N-oxide: A Novel Biomarker for the Identification of Inflammatory Bowel Disease.Metabonomics uncovers a reversible proatherogenic lipid profile during infliximab therapy of inflammatory bowel disease.Metabolomics for the masses: The future of metabolomics in a personalized world.A lipidomics investigation into the intervention of celastrol in experimental colitis.Potential Application of 1H NMR for Routine Serum Lipidome Analysis -Evaluation of Effects of Bariatric Surgery.NMR-based metabolomic techniques identify potential urinary biomarkers for early colorectal cancer detection.Magnolol, a Natural Polyphenol, Attenuates Dextran Sulfate Sodium-Induced Colitis in Mice.Analysis of Exhaled Breath Volatile Organic Compounds in Inflammatory Bowel Disease: A Pilot Study.Significance of non-alcoholic fatty liver disease in Crohn's disease: A retrospective cohort study.Faecal and Serum Metabolomics in Paediatric Inflammatory Bowel Disease.Metabolomic profile of systemic sclerosis patients.Emerging concepts in non-invasive monitoring of Crohn's disease.
P2860
Q26748735-B3A922E2-5CF2-4DE4-99C3-C02D24AF0219Q26781298-F23518CF-B6D2-43D6-9F2D-018F592C97FDQ28076129-09E1CD81-810C-4994-A5D6-1A1EE50CAE70Q28078126-EBC4D4FD-3D93-4693-81E9-ECF9BC3F9B2AQ28080959-5C2E0580-D365-43A7-ABAB-9676145375F6Q28083342-9E2A4575-8B92-4122-AFCB-D7D4DF4F99D5Q29247903-078B0997-BE6E-4325-8C5C-486438BFB635Q30241940-E0A5E173-2385-458A-8D3D-B04175CF718EQ33786052-F1658392-9AF7-4EF1-BB0E-678A521BDE7DQ34900690-183B6A0D-AABB-49AB-977B-73A76504FB0EQ35701279-19FA1F42-4581-4A90-A228-E9CEA08D298CQ36127459-F098B664-84DD-4152-896C-A5F76892EAC3Q36251478-932FD1A2-D8DB-4B22-B476-804E53BE30CDQ37303691-D5D2138C-A3FF-44DB-BB91-AD842CF5E138Q38230162-8C520190-4BB8-44F8-A4B9-D911B8D9C042Q38617974-FAD083A1-122D-45F7-8EA3-3110811142FEQ39270927-027FAFEE-9D4A-4FD3-88E8-588E8D757BDEQ40507229-4B60D4EC-4AC0-495A-98C7-82C1E919C5ACQ40752459-B6063BB4-B602-4EA9-AC43-D774AC44D4D9Q42378152-BB4E9991-5D6D-4559-BD91-BA554A5BECB1Q44951888-ED3C1419-52BD-4910-A465-C8DED45F72FDQ46572722-D362CBF0-6A1E-4516-896E-F679D653B7C8Q47096344-AFAA2277-8EAE-49A7-98FA-A1B5BC279BC3Q47130798-93E0DBEF-0A50-437F-B5AB-A2EFE5106C46Q47964364-1080DB1D-091B-4977-B6F7-36EC4BEE93BCQ48791026-9BFB1E0B-0C38-40CB-A5E2-D1431E7D49A8Q51397368-150AA6FD-A3AA-4C0C-80EA-4C079B9A6D01Q51526875-D1B6F4CD-79E0-448C-A202-D2162D9641CBQ55191669-B2963E5D-5DB4-4652-9E6A-B6A53B8D4776Q55364545-71FCD41A-3227-448D-985A-308D28D478F9
P2860
Serum and urine metabolomic fingerprinting in diagnostics of inflammatory bowel diseases
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Serum and urine metabolomic fingerprinting in diagnostics of inflammatory bowel diseases
@en
Serum and urine metabolomic fingerprinting in diagnostics of inflammatory bowel diseases.
@nl
type
label
Serum and urine metabolomic fingerprinting in diagnostics of inflammatory bowel diseases
@en
Serum and urine metabolomic fingerprinting in diagnostics of inflammatory bowel diseases.
@nl
prefLabel
Serum and urine metabolomic fingerprinting in diagnostics of inflammatory bowel diseases
@en
Serum and urine metabolomic fingerprinting in diagnostics of inflammatory bowel diseases.
@nl
P2093
P2860
P50
P921
P356
P1476
Serum and urine metabolomic fingerprinting in diagnostics of inflammatory bowel diseases
@en
P2093
Adam Litarski
Adam Ząbek
Agata Mulak
Dorota Pawełka
Ewa Jawień
Kornel Pormańczuk
Krzysztof Korta
Mirosław Banasik
Piotr Barć
P2860
P304
P356
10.3748/WJG.V20.I1.163
P407
P577
2014-01-01T00:00:00Z